Health Care: Drugs

Immunomedics Inc (IMMU: NASDAQ)

$3.28 n/a | n/a%
12/05/16 - 04:00 PM ET
Company Income Statement
Jun 2016 Jun 2015 Jun 2014 Jun 2013
Sales 3.23M 5.65M 9.04M 4.96M
Cost of Sales 1.16M 264.92K 3.30M 392.72K
Gross Operating Profit 2.07M 5.39M 5.74M 4.57M
Selling, General, and Administrative Expenses 7.59M 9.87M 9.41M 6.98M
Research & Development 53.49M 41.74M 33.68M 28.38M
Operating Income before D & A (EBITDA) -59.01M -46.22M -37.36M -30.79M
Depreciation & Amortization 2.03M 1.50M -1.78M 958.88K
Interest Income 337.90K 245.71K 55.92K 10.56K
Other Income - Net -39.54K -1.19K 938.00 19.34M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -60.74M -47.47M -35.52M -12.40M
Interest Expense 5.48M 2.09M 0.00 0.00
Pre-Tax Income -66.22M -49.56M -35.52M -12.40M
Income Taxes -5.05M 58.23K 7.79K 44.07K
Minority Interest -98.77K -121.61K -105.35K -104.76K
Net Income From Continuing Operations -59.14M -48.12M -35.53M -11.49M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -59.14M -48.12M -35.53M -11.49M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -59.04M -48.00M -35.43M -11.38M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-59.14M -48.12M -35.53M -11.49M
Preferred Dividends
Net Income Available To Common -59.14M -48.12M -35.53M -11.49M
Basic EPS from Continuing Ops. -0.62 -0.51 -0.42 -0.15
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.62 -0.51 -0.42 -0.15
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.62 -0.51 -0.42 -0.15
Basic Normalized Net Income/Share -0.62 -0.51 -0.42 -0.15
EPS fr Continuing Ops. -0.62 -0.51 -0.42 -0.15
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.62 -0.51 -0.42 -0.15
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.62 -0.51 -0.42 -0.15
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.62 -0.51 -0.42 -0.15
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IMMU

Latest IMMU Headlines from TheStreet

More Financial News for IMMU

Press Releases for IMMU

See All Press Releases

Partner Headlines for IMMU

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter